|
Volumn 76, Issue 1, 2000, Pages 1-2
|
Does brain penetration of anti-HIV drugs matter?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
DIDANOSINE;
PROTEINASE INHIBITOR;
VIRUS RNA;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DRUG BRAIN LEVEL;
DRUG CEREBROSPINAL FLUID LEVEL;
DRUG PENETRATION;
EDITORIAL;
ERADICATION THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
PRIORITY JOURNAL;
AIDS DEMENTIA COMPLEX;
ANTI-HIV AGENTS;
BRAIN;
DIDANOSINE;
HIV-1;
HUMANS;
ZIDOVUDINE;
|
EID: 0034030635
PISSN: 13684973
EISSN: None
Source Type: Journal
DOI: 10.1136/sti.76.1.1 Document Type: Editorial |
Times cited : (6)
|
References (0)
|